Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

D Cushing

Showing results (41-50 of 50) with videos related to

Pageof 5
Sort By:
You have reached the last page of results.This site can display upto 50 results.
Bioorganic & Medicinal Chemistry Letters|July 4, 2006
Discovery of a novel series of inhibitors of human cytomegalovirus primaseT D Cushing, J Adrian, X Chen, et al.
Bioorganic & Medicinal Chemistry Letters|February 5, 2013
Inhibiting NF-κB-inducing kinase (NIK): discovery, structure-based design, synthesis, structure-activity relationship, and co-crystal structuresKexue Li, Lawrence R McGee, Ben Fisher, et al.
Bioorganic & Medicinal Chemistry Letters|February 11, 2015
Synthesis and SAR study of potent and selective PI3Kδ inhibitorsMinna Bui, Xiaolin Hao, Youngsook Shin, et al.
Journal of Medicinal Chemistry|December 15, 2015
Discovery, Optimization, and in Vivo Evaluation of Benzimidazole Derivatives AM-8508 and AM-9635 as Potent and Selective PI3Kδ InhibitorsYoungsook Shin, Julia Suchomel, Mario Cardozo, et al.
Journal of Medicinal Chemistry|August 11, 2012
Discovery and in vivo evaluation of dual PI3Kβ/δ inhibitorsFelix Gonzalez-Lopez de Turiso, Youngsook Shin, Matthew Brown, et al.
Bioorganic & Medicinal Chemistry|January 9, 2013
Discovery of INT131: a selective PPARγ modulator that enhances insulin sensitivityJoshua P Taygerly, Lawrence R McGee, Steven M Rubenstein, et al.
Journal of Medicinal Chemistry|July 15, 2016
Discovery and in Vivo Evaluation of the Potent and Selective PI3Kδ Inhibitors 2-((1S)-1-((6-Amino-5-cyano-4-pyrimidinyl)amino)ethyl)-6-fluoro-N-methyl-3-(2-pyridinyl)-4-quinolinecarboxamide (AM-0687) and 2-((1S)-1-((6-Amino-5-cyano-4-pyrimidinyl)amino)ethyl)-5-fluoro-N-methyl-3-(2-pyridinyl)-4-quinolinecarboxamide (AM-1430)Felix Gonzalez-Lopez de Turiso, Xiaolin Hao, Youngsook Shin, et al.
Bioorganic & Medicinal Chemistry Letters|November 16, 2010
A novel series of IKKβ inhibitors part II: description of a potent and pharmacologically active series of analogsTimothy D Cushing, Vijay Baichwal, Karen Berry, et al.
Bioorganic & Medicinal Chemistry Letters|November 16, 2010
A novel series of IKKβ inhibitors part I: Initial SAR studies of a HTS hitTimothy D Cushing, Vijay Baichwal, Karen Berry, et al.
Journal of Medicinal Chemistry|December 4, 2014
Discovery and in vivo evaluation of (S)-N-(1-(7-fluoro-2-(pyridin-2-yl)quinolin-3-yl)ethyl)-9H-purin-6-amine (AMG319) and related PI3Kδ inhibitors for inflammation and autoimmune diseaseTimothy D Cushing, Xiaolin Hao, Youngsook Shin, et al.
Pageof 5

Showing results (41-50 of 50) with videos related to

Sort By:
Pageof 5
You have reached the last page of results.This site can display upto 50 results.
Bioorganic & Medicinal Chemistry Letters|July 4, 2006
Discovery of a novel series of inhibitors of human cytomegalovirus primaseT D Cushing, J Adrian, X Chen, et al.
Bioorganic & Medicinal Chemistry Letters|February 5, 2013
Inhibiting NF-κB-inducing kinase (NIK): discovery, structure-based design, synthesis, structure-activity relationship, and co-crystal structuresKexue Li, Lawrence R McGee, Ben Fisher, et al.
Bioorganic & Medicinal Chemistry Letters|February 11, 2015
Synthesis and SAR study of potent and selective PI3Kδ inhibitorsMinna Bui, Xiaolin Hao, Youngsook Shin, et al.
Journal of Medicinal Chemistry|December 15, 2015
Discovery, Optimization, and in Vivo Evaluation of Benzimidazole Derivatives AM-8508 and AM-9635 as Potent and Selective PI3Kδ InhibitorsYoungsook Shin, Julia Suchomel, Mario Cardozo, et al.
Journal of Medicinal Chemistry|August 11, 2012
Discovery and in vivo evaluation of dual PI3Kβ/δ inhibitorsFelix Gonzalez-Lopez de Turiso, Youngsook Shin, Matthew Brown, et al.
Bioorganic & Medicinal Chemistry|January 9, 2013
Discovery of INT131: a selective PPARγ modulator that enhances insulin sensitivityJoshua P Taygerly, Lawrence R McGee, Steven M Rubenstein, et al.
Journal of Medicinal Chemistry|July 15, 2016
Discovery and in Vivo Evaluation of the Potent and Selective PI3Kδ Inhibitors 2-((1S)-1-((6-Amino-5-cyano-4-pyrimidinyl)amino)ethyl)-6-fluoro-N-methyl-3-(2-pyridinyl)-4-quinolinecarboxamide (AM-0687) and 2-((1S)-1-((6-Amino-5-cyano-4-pyrimidinyl)amino)ethyl)-5-fluoro-N-methyl-3-(2-pyridinyl)-4-quinolinecarboxamide (AM-1430)Felix Gonzalez-Lopez de Turiso, Xiaolin Hao, Youngsook Shin, et al.
Bioorganic & Medicinal Chemistry Letters|November 16, 2010
A novel series of IKKβ inhibitors part II: description of a potent and pharmacologically active series of analogsTimothy D Cushing, Vijay Baichwal, Karen Berry, et al.
Bioorganic & Medicinal Chemistry Letters|November 16, 2010
A novel series of IKKβ inhibitors part I: Initial SAR studies of a HTS hitTimothy D Cushing, Vijay Baichwal, Karen Berry, et al.
Journal of Medicinal Chemistry|December 4, 2014
Discovery and in vivo evaluation of (S)-N-(1-(7-fluoro-2-(pyridin-2-yl)quinolin-3-yl)ethyl)-9H-purin-6-amine (AMG319) and related PI3Kδ inhibitors for inflammation and autoimmune diseaseTimothy D Cushing, Xiaolin Hao, Youngsook Shin, et al.
Pageof 5